糖心国产传媒vlog|swag观看|麻豆传媒映画张琳琳|91传媒制片厂苹果|麻豆传媒国产之光 ed2k|91果冻麻豆制片厂网站|吃瓜的最高境界|麻豆传媒下载app下载最新版|一级α片|91碰,91麻豆黄色在线观看,狠狠操狠狠干,爱豆世纪文化传媒打赏骗人的吗,色在线综合,久久只有精品国产av,自拍偷拍亚洲熟女妇人精品

Home> Latest

Hangzhou group develops robot to aid for surgical operations

ehangzhou.gov.cn| Updated: May 20, 2020 L M S

hangzhou+company+hip replacement.jpg

Doctors at the Second Affiliated Hospital of Xi'an Jiaotong University perform an operation, using a seven-axis surgical robot developed by Hangzhou Keya robot Co Ltd. [Photo/WeChat account: xianjiaodaerfuyuan]

A seven-axis robot developed by a company in Hangzhou - - the capital of China's eastern Zhejiang province -- recently assisted doctors at the Second Affiliated Hospital of Xi'an Jiaotong University, to successfully complete a total hip joint replacement operation.

Experts said the operation was the first of its kind in China.

The robot named "ARTHROBOT" was developed by Hangzhou Keya robot Co Ltd, which was founded in Hangzhou Future Sci-Tech City in 2018.

The company specializes in providing targeted joint replacement medical solutions and is experienced in developing surgical robots.

According to Xu Jing, founder of the company, ARTHROBOT is a seven-axis robot which has a high level of dexterity similar to a human's arms.

In 2019, China had more than 700,000 surgical operations carried out for joint replacements and experts say the number keeps growing at an annual rate of 20 percent.

Experts say there is a lack of accuracy in operating on hip joint replacements and the development of ARTHROBOT helps fill the gap.

Wang Zhengkun, director of the joint surgery department at the Second Affiliated Hospital of Xi'an Jiaotong University and the main operator of the surgery, said that doctors can achieve a high degree of accuracy using the seven-axis robot independently developed by the Chinese company to conduct joint replacement surgery.

Xu said that the robot has entered a clinical trial phase and is expected to be the first domestic joint replacement surgical robot approved by the National Medical Products Administration.

     
1 2 3 4